marginally significantP=0.08
Furthermore, we observed a marginally significant lower breast density with simultaneous use of metformin and aspirin (OR=0.44, P=0.08) compared with nonusers.
Furthermore, we observed a marginally significant lower breast density with simultaneous use of metformin and aspirin (OR=0.44, P=0.08) compared with nonusers.